Charles Jiang, M.D., M.P.H., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He specializes in genitourinary medical oncology with an emphasis on prostate, bladder, kidney, and testis cancer.

Dr. Jiang earned his medical degree at the Medical College of Soochow University in Suzhou, China. He completed an internal medicine residency at the Icahn School of Medicine at Mount Sinai in New York and received advanced training through a fellowship in medical oncology and hematology at the Roswell Park Comprehensive Cancer Center and the University at Buffalo. He also holds a Master of Public Health in chronic disease epidemiology from Yale University.

Certified by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2023.

Dr. Jiang is a member of several professional societies, including the American Society of Clinical Oncology (ASCO), the Multinational Association of Supportive Care in Cancer, and the American Association for Cancer Research.

His research interests include how to improve cancer survivorship and quality of life and reduce cancer-related health disparities. He has contributed to multiple publications and abstracts and given several presentations in his areas of expertise.

In 2023, Dr. Jiang earned the Conquer Cancer Merit Awards from the ASCO Annual Meeting and the ASCO Quality Symposium.

Personal Note

When not at work, Dr. Jiang enjoys exploring various cuisines.


Medical School
Soochow Medical College (2014)
Undergraduate School
Yale School of Public Health (2016)
Icahn School of Medicine at Mt Sinai/Mount Sinai Morningside/West (2018)
Icahn School of Medicine at Mount Sinai (2020), Internal Medicine
University at Buffalo Roswell Park Comprehensive Cancer Center (2023), Hematology Oncology


Featured Publications LegendFeatured Publications

Medicaid expansion and racial disparity in timely multidisciplinary treatment in muscle invasive bladder cancer.
Jiang C, Perimbeti S, Deng L, Xing J, Chatta GS, Han X, Gopalakrishnan D, J Natl Cancer Inst 2023 Oct 115 10 1188-1193
Subjective and Objective Hearing Loss Among US Adult Cancer Survivors.
Wang Q, Jiang C, Wen C, Xie H, Li Y, Zhang Y, Mady LJ, Bruno DS, Dutcher GMA, Chiec LS, Dowlati A, Hsu ML, JAMA Otolaryngol Head Neck Surg 2023 Oct
Response to Lin and Lin.
Jiang C, Yabroff KR, Han X, J Natl Cancer Inst 2023 Sep
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
Han X, Yang NN, Nogueira L, Jiang C, Wagle NS, Zhao J, Shi KS, Fan Q, Schafer E, Yabroff KR, Jemal A, Lancet Oncol 2023 Aug 24 8 855-867
Transportation barriers, emergency room use, and mortality risk among US adults by cancer history.
Jiang C, Yabroff KR, Deng L, Wang Q, Perimbeti S, Shapiro CL, Han X, J Natl Cancer Inst 2023 Jul 115 7 815-821
Vertical integration of oncologists and cancer outcomes and costs in metastatic castration-resistant prostate cancer.
Hu X, Lipscomb J, Jiang C, Graetz I, J Natl Cancer Inst 2023 Mar 115 3 268-278
Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S.
Zhu C, Shi T, Jiang C, Liu B, Baldassarre LA, Zarich S, JACC CardioOncol 2023 Feb 5 1 55-66
Dobbs v Jackson and access to fertility care among newly diagnosed adolescents and young adults with cancer in the USA.
Jiang C, Yabroff KR, Hill MJ, Han X, Lancet Oncol 2022 Oct 23 10 1240-1243
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors.
Jiang C, Yabroff KR, Deng L, Wang Q, Perimbeti S, Shapiro CL, Han X, JAMA Oncol 2022 05 8 5 775-778
Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018.
Jiang C, Deng L, Karr MA, Wen Y, Wang Q, Perimbeti S, Shapiro CL, Han X, Cancer 2022 Feb 128 4 828-838